These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Salvage therapy for patients failing their current antiretroviral regimen. Albrecht MA AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220 [No Abstract] [Full Text] [Related]
5. [New trends in HIV]. Volkert R Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287 [No Abstract] [Full Text] [Related]
6. [HIV viral dynamic after antiretroviral treatment initiation: is a rapid decay a good pronostic?]. Delaugerre C Pathol Biol (Paris); 2010 Dec; 58(6):403-5. PubMed ID: 19481371 [No Abstract] [Full Text] [Related]
8. Update of the drug resistance mutations in HIV-1: 2004. Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709 [No Abstract] [Full Text] [Related]
9. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885 [No Abstract] [Full Text] [Related]
10. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS). De Clercq E Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005 [TBL] [Abstract][Full Text] [Related]
11. Targeting HIV: antiretroviral therapy and development of drug resistance. Menéndez-Arias L Trends Pharmacol Sci; 2002 Aug; 23(8):381-8. PubMed ID: 12377580 [TBL] [Abstract][Full Text] [Related]
12. Antiviral treatment of HIV infection. Thomas MG; Ellis-Pegler RB N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818 [No Abstract] [Full Text] [Related]
13. [The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage]. Duval X Presse Med; 2000 Feb; 29(5):253-6. PubMed ID: 10701407 [No Abstract] [Full Text] [Related]
14. Developing long-term treatment strategies. PI Perspect; 1996 Sep; (No 19):11-4. PubMed ID: 11363897 [TBL] [Abstract][Full Text] [Related]